Despite significant improvements in reperfusion strategies, acute coronary syndromes all too
often culminate in a myocardial infarction (MI). The consequent MI can, in turn, lead to …

Myocardial infarction is a prevalent major cardiovascular event that arises from myocardial
ischemia with or without reperfusion, and basic and translational research is needed to …

Approximately 7 million people are affected by acute myocardial infarction (MI) each year,
and despite significant therapeutic and diagnostic advancements, MI remains a leading …

Preclinical models with high prognostic power are a prerequisite for translational research.
The closer the similarity of a model to myocardial infarction (MI), the higher is the prognostic …

Animal models of cardiovascular pathology contribute towards understanding and treatment
of a broad range of conditions. Specifically in the context of acute myocardial infarction …

With heart failure leading the cause of death in the USA (Hunt), biomedical research is
fundamental to advance medical treatments for cardiovascular diseases. Animal models that …

Sustainable and reproducible large animal models that closely replicate the clinical
sequelae of myocardial infarction (MI) are important for the translation of basic science …

There is a lack of understanding in the cardiac remodeling field regarding the use of
nonreperfused myocardial infarction (MI) and reperfused MI in animal models of MI. This …

Myocardial infarction (MI) is a disease of major consequence in the modern world, causing
permanent, irreversible damage to the heart. Survivors are at risk for developing further …

Ischemia–reperfusion injury (IRI) is a major, but potentially preventable contributor to the
final tissue damage after an acute myocardial infarction. Many therapies have demonstrated …